Related Experiment Video
Updated: Sep 15, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
Adjuvant chemotherapy for bladder cancer. Standard of care or unproven therapy?
R R Bahnson1, D Smith, D Trump
1University of Pittsburgh, School of Medicine, Pennsylvania, USA.
Abstract:
The failure of radical cystectomy to cure the majority of patients with muscle invasive transitional cell carcinoma of the bladder has prompted clinical trials evaluating adjuvant chemotherapy. No properly conducted prospective trials are available to support unequivocally the application of pre- or postsurgical chemotherapy. A large trial comparing chemotherapy with no chemotherapy and standard treatment (cystectomy) is nearing completion. The results will determine whether or not adjuvant chemotherapy becomes the standard of care.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention